— Know what they know.
Not Investment Advice
Also trades as: IMC.AX (ASX) · $vol 0M

IMRN NASDAQ

Immuron Limited
1W: -6.0% 1M: -6.8% 3M: -2.7% YTD: +37.1% 1Y: -42.9% 3Y: -43.5% 5Y: -77.5%
$1.09
-0.04 (-3.54%)
 
Weekly Expected Move ±33.7%
$0 $1 $1 $1 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 52 · $7.0M mcap · 7M float · 23.97% daily turnover · Short 30% of daily vol

Balance Sheet Trends

Total Assets
$13M +28.7% ▲
5Y CAGR: -13.6%
Total Liabilities
$2M -3.6% ▼
5Y CAGR: +11.4%
Shareholders Equity
$11M +37.0% ▲
5Y CAGR: -15.7%
Cash & Investments
$9M +53.7% ▲
5Y CAGR: -18.5%
Total Debt
$0 -100.0% ▼
Net Debt
-$9M -232.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$22M$17M$12M$3M$9M
Short-Term Investments$0$2M$0$3M$0
Cash & ST Investments$22M$19M$12M$6M$9M
Net Receivables$663K$417K$1M$791K$1M
Inventory$327K$840K$2M$2M$2M
Other Current Assets$0$0$0-$2M$258K
Total Current Assets$24M$20M$15M$10M$13M
Property, Plant & Equip.$227K$200K$154K$114K$193K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$159K$0$0$0
Other Non-Current Assets$957K$1M$669K$666$0
Total Non-Current Assets$1M$2M$824K$115K$193K
Total Assets$25M$22M$16M$10M$13M
— Liabilities —
Accounts Payable$721K$791K$649K$2M$1M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$698K$0$0$0
Other Current Liabilities$536K$402K$523K$0$440K
Total Current Liabilities$2M$2M$3M$2M$2M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$36$2K$9K$23K$201K
Total Non-Current Liabilities$175K$152K$142K$95K$201K
Total Liabilities$2M$2M$3M$2M$2M
— Equity —
Common Stock$88M$88M$89M$89M$96M
Retained Earnings-$68M-$72M-$79M-$82M-$85M
Accumulated OCI$3M$3M$3M$2M$480K
Total Stockholders Equity$23M$20M$13M$8M$11M
Total Liabilities & Equity$25M$22M$16M$10M$13M
— Key Metrics —
Total Debt$210K$189K$173K$117K$0
Net Debt-$22M-$17M-$11M-$3M-$9M
Total Investments$0$2M$0$3M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms